Login Register Cart 0

Articles by Disease (Vascular Diseases)

A Rationale for Curcuminoids for the Prevention or Treatment of Alzheimers Disease

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 3
Page: 15-25
Author(s): G. M. Cole, F. Yang, G. P. Lim, J. L. Cummings, D. L. Masterman and S. A. Frautschy

Oxidative Mediated Neurodegeneration in Alzheimers Disease: Melatonin and Related Indoles as Neuroprotective Agents

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 3
Page: 33-46
Author(s): M. A. Pappolla, R. J. Reiter, T. K. Bryant-Thomas and B. Poeggeler

Immunotoxin Lesion of the Cholinergic Nucleus Basalis Causes Aβ Deposition: Towards a Physiologic Animal Model of Alzheimers Disease

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 3
Page: 57-75
Author(s): T. G. Beach, D. G. Walker, L. I. Sue, S. Scott, K. J. Layne, A. J. Newell, P. E. Potter, R. A. Durham, M. R. Emmerling and S. D. Webster

Appraisal of AβPP Transgenic Mice as Models for Alzheimers Disease Amyloid Cascade

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 3
Page: 85-90
Author(s): Alex E. Roher and Tyler A. Kokjohn

Novel Approaches to Anti-Inflammatory Agents as Therapeutics for Asthma

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 2
Page: 9-18
Author(s): Ayla Balkan and Barkin Berk

Tachykinins as Therapeutic Targets in Inflammation

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 2
Page: 19-27
Author(s): M. Bhatia

NF-κB as a Therapeutic Target for Transcription Factor Decoy Strategy in Inflammatory Diseases

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 2
Page: 51-56
Author(s): Naruya Tomita, Ryuichi Morishita, Tetsuya Tomita, Haruhito Azuma and Toshio Ogihara

Retinoids: Pleiotropic Agents of Therapy for Vascular Diseases?

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 3
Page: 31-57
Author(s): Jeffrey W. Streb and Joseph M. Miano

RAS Blockade in Experimental Renal Transplantation. Benefits and Limitations

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 3
Page: 73-79
Author(s): Annemieke Smit-van Oosten, Coen A. Stegeman and Harry van Goor

Unfolding the Pathophysiological Role of Bioactive Lysophospholipids

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 3
Page: 23-32
Author(s): Yan Xu, Yi-jin Xiao, Kui Zhu, Linnea M. Baudhuin, Jun Lu, Guiying Hong, Kwan-sik Kim, Kelly L. Cristina, Li Song and Freager S. Williams